However, a younger generation has opted to find new ways to get their daily dose of caffeine, which has driven energy drinks ...

The U.S. Food & Drug Administration has approved Johnson & Johnson's device for a type of condition which causes abnormal ...

The first time Johnson & Johnson faced a lawsuit due to its talc-based baby powder causing cancer was way back in 1999.

Guggenheim raised the firm’s price target on Johnson & Johnson to $162 from $156 and keeps a Neutral rating on the shares. The firm ...

Dwayne Johnson, AKA The Rock, has revealed his future plans with WWE, both as a professional wrestler and as a member of the ...

Johnson & Johnson Stock Performance Shares of NYSE:JNJ opened at $160.14 on Wednesday. The company has a market cap of $385.41 billion, a P/E ratio of 9.98, a PEG ratio of 2.90 and a beta of 0.52 ...

It was one year ago this month that Ashley McEvoy announced her surprising resignation as worldwide chair of J&J MedTech. She ...

Johnson Controls (JCI) reports Q3 results, beats earnings expectations, and initiates guidance for fiscal 2025. Stock up 31% ...

Analyst Andrew Obin from Bank of America Securities reiterated a Buy rating on Johnson Controls (JCI – Research Report) and keeping the ...

The company reported $2.42 earnings per share for the quarter, topping analysts’ consensus estimates of $2.21 by $0.21. Johnson & Johnson had a net margin of 19.14% and a return on equity of 35.46%.

George E. Johnson an entrepreneur with a high school education who parlayed a $250 investment into a company that grossed $39 ...

ONL Therapeutics Inc. is a classic case of a University of Michigan spinout. The Ann Arbor biotechnology startup netted the largest VC deal in the state in Q3, closing an oversubscribed $65 million ...